Search
for
Sort by
Research 211–240 of 1000+
- The Evaluation and Management of Hirsutism
- Immunomodulators in the treatment of cutaneous lymphoma
- Androgen excess and post-reproductive health
- Endocrinopathies and Other Disorders Inducing a Polycystic Ovary Syndrome Phenotype
- Androgens and the Menopause
- Diagnosis and treatments of hirsutism: where are we?
- Generalised Glucocorticoid Resistance
- A case of severe hyperandrogenism, acanthosis nigricans and overt diabetes: the use of non-invasive methods for diagnosis, pathogenesis and management
- The Effect of Finasteride on Serum Cortisol and testosterone Levels in Rats
- Serum level of Apelin-12 in acne patients: Is it a marker of disease severity?
- Controversies in Polycystic Ovary Syndrome
- Modelling androgen synthesis and action during human sexual differentiation
- Registrars’ Symposium: Summaries of Papers
- Acne as a chronic systemic disease
- Toward a Diagnostic Score in Cushing's Syndrome
- Urinary steroids in women with androgenic alopecia
- Acne-Associated Syndromes
- American Academy of Veterinary Dermatology and American College of Veterinary Dermatology Annual Meeting, Norfolk, Virginia 4-8 April 2001
- Obesity and the skin: Skin physiology and skin manifestations of obesity
- Hormones
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane
- Neuroendocrinology of the hair follicle: principles and clinical perspectives
- Safety of testosterone treatment in postmenopausal women
- Exploring the “Thyroid–Skin Connection”: Concepts, Questions, and Clinical Relevance
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Cushing Syndrome from Percutaneous Absorption of 1% Hydrocortisone Ointment in Netherton Syndrome
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?